Morgan Stanley Maintains Overweight on Zimmer Biomet Holdings, Raises Price Target to $175

Morgan Stanley maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Overweight and raises the price target from $170 to $175.

Benzinga · 02/05/2020 13:32

Morgan Stanley maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Overweight and raises the price target from $170 to $175.